IS THERE ANY POINT INCARDIOMETABOLIC THERAPY IN THE TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE AND TYPE 2 DIABETES MELLITUS? (literature review)
| Autor: | L. V. Zhuravlyova, N. A. Lopina |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
business.industry Endocrinology Diabetes and Metabolism medicine.medical_treatment Ischemia Type 2 Diabetes Mellitus medicine.disease Revascularization Cytoprotection Pathology and Forensic Medicine Coronary artery disease Endocrinology Internal medicine medicine Cardiology cardiovascular diseases business Standard therapy Metabolic therapy |
| Zdroj: | Problems of Endocrine Pathology. 58:105-120 |
| ISSN: | 2518-1432 2227-4782 |
| Popis: | The article focused on coronary artery disease, as it takes a leading place in the structure of cardiovascular morbidity and mortality. The article described pathogenetic mechanisms of influence the ischemia on the myocardium, particularly of energy production in the myocardium in norm and ischemia. The basic therapeutic strategies to reducing ischemia were described. Discussed reasons for the persistence of pain in the heart after «successful» revascularization. Substantiated along with the standard therapy the use of cardiometabolic medications in cytoprotection ischemia. The article described the classification cytoprotectors on the specifics of the pharmacological effect. Substantiated clinical application of Mexicor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|